New Stock Update: Dragon Pharma & Peptide Hubs Additions
We're pleased to announce a major stock update featuring new arrivals from Dragon Pharma and Peptide Hubs. Whether you're optimizing your performance, recovery, or overall wellness, these fresh additions are now available for immediate order from our international and USA domestic warehouses.
🧬 New Dragon Pharma Products
Drug Class: Selective Estrogen Receptor Modulator (SERM)
Composition: Enclomiphene
Dosage: 25 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Amino Acid Derivative, Fat Transport Agent
Composition: Levocarnitine (L-Carnitine Base)
Dosage: 500 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Mitochondrial-Derived Peptide (MDP)
Composition: Mitochondrial Open Reading Frame of the 12S rRNA-c
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Injectable Use After Reconstitution
Drug Class: Myostatin Inhibitor / Small Molecule Peptide
Composition: SLU-PP-332
Dosage: 500 mcg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
💉 New Peptide Hubs Products
🚀 Order Now While Supplies Last
All the above products are now in stock and available for immediate purchase. These additions expand our growing catalog of premium peptides and wellness compounds, ensuring our customers have access to the latest in performance science.
Stay tuned for more upcoming arrivals, lab-tested product verifications, and seasonal promotions. You can explore our full range directly through the Dragon Pharma store and Peptide Hubs section.
News
Celebrate the holiday season with our exclusive Christmas Sale! Enjoy up to 30% off top brands like British Dragon, Kalpa Pharmaceuticals, Axiolabs, and more. Discounts are automatically applied—no code needed. Sale ends on 01-01-2025!
Gynecomastia is generally the medical term used to refer to a development of breast tissues in male steroid users. This commonly occurs when a male steroid user is presented with the unusually very high level of estrogen in the body, out of steroid use.
British Dragon Pharma announced today that it presented pre-clinical data suggesting its transmucosal insulin can deliver significant dosages of insulin into the bloodstream
Customer Reviews
Please leave your review on products or service below.
Thank you beforehand.